| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.6M | +21.3% |
| Cost of Revenue | $8.7M | +140.1% |
| Gross Profit | -$5.1M | -707.1% |
| R&D Expense | $37.6M | +41.8% |
| SG&A Expense | $36.8M | +44.1% |
| Operating Income | -$98.8M | -56.3% |
| Income Tax | $58K | — |
| Net Income | -$98.7M | -51.8% |
| EPS (Basic) | -$0.63 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.1M | +34.4% |
| Accounts Receivable | $617K | -85.4% |
| Inventory | $4.6M | +11.5% |
| Current Assets | $105.5M | -40.5% |
| Total Assets | $133.3M | -28.4% |
| Current Liabilities | $22.6M | +66.3% |
| Long-term Debt | $0 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$71.6M | -28.6% |
| Capital Expenditures | $4.2M | +311.4% |
| Investing Cash Flow | $68.5M | +145.2% |
| Financing Cash Flow | $8.1M | -96.1% |
| Free Cash Flow | -$75.8M | -33.7% |
| -5.0% |
| EPS (Diluted) | -$0.63 | -5.0% |
| Total Liabilities |
| $39.4M |
| +126.4% |
| Stockholders' Equity | $94.0M | -44.3% |